Mark Hall to Informed Consent
This is a "connection" page, showing publications Mark Hall has written about Informed Consent.
Connection Strength
0.892
-
Hall MA, King NM, Perdue LH, Hilner JE, Akolkar B, Greenbaum CJ, McKeon C. Biobanking, consent, and commercialization in international genetics research: the Type 1 Diabetes Genetics Consortium. Clin Trials. 2010; 7(1 Suppl):S33-45.
Score: 0.353
-
Richman B, Hall M, Schulman K. The No Surprises Act and Informed Financial Consent. N Engl J Med. 2021 Oct 07; 385(15):1348-1351.
Score: 0.199
-
Richman BD, Hall MA, Schulman KA. Overbilling and informed financial consent--a contractual solution. N Engl J Med. 2012 Aug 02; 367(5):396-7.
Score: 0.105
-
Fortune-Greeley AK, Hardy NC, Lin L, Friedman JY, Lawlor JS, Muhlbaier LH, Hall MA, Schulman KA, Sugarman J, Weinfurt KP. Patient reactions to confidentiality, liability, and financial aspects of informed consent in cardiology research. Circ Cardiovasc Qual Outcomes. 2010 Mar; 3(2):151-8.
Score: 0.088
-
Hall MA. Law, medicine, and trust. J Nurs Law. 2003 May; 9(1):33-84.
Score: 0.056
-
Hall MA. Law, medicine, and trust. Stanford Law Rev. 2002 Nov; 55(2):463-527.
Score: 0.054
-
Weinfurt KP, Hall MA, Friedman JY, Hardy C, Fortune-Greeley AK, Lawlor JS, Allsbrook JS, Lin L, Schulman KA, Sugarman J. Effects of disclosing financial interests on participation in medical research: a randomized vignette trial. Am Heart J. 2008 Oct; 156(4):689-97.
Score: 0.020
-
Weinfurt KP, Friedman JY, Dinan MA, Allsbrook JS, Hall MA, Dhillon JK, Sugarman J. Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators. J Law Med Ethics. 2006; 34(3):581-91, 481.
Score: 0.017